Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

NCT00019123 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: thalidomide

Sponsor

National Cancer Institute (NCI)